Clinical trial
The Transmission of Artemisinin Resistant Parasites Before and After Conventional Artemisinin-combination Therapy: a Longitudinal Study
NCT06347471 is registered in ClinicalTrials.gov with Infectious Diseases Research Collaboration, Uganda as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Transmission of Artemisinin Resistant Parasites Before and After Conventional Artemisinin-combination Therapy: a Longitudinal Study
- Lead sponsor
- Infectious Diseases Research Collaboration, Uganda
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- May 28, 2024
- Completion date
- November 22, 2025
- Enrollment
- 160 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
falciparum; malaria